Trial Profile
multicenter lymphangioleiomyomatosis sirolimus trial for safety
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 May 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Lymphangioleiomyomatosis
- Focus Adverse reactions
- 30 May 2016 New trial record